Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETN for secondary prevention of intrauterine growth restriction
2016-004396-51Phase 3Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intrauterine growth restriction (IUGR), placental insufficiency and Pregnancy-related complication comparing PETN with Placebo (2 arms). Primary endpoint: development of intrauterine growth restriction (IUGR). Started Feb 2017; status: completed.
02
Drugs
pentaerythrityl tetranitrate
03
Conditions
intrauterine growth restriction (IUGR)placental insufficiencyPregnancy-related complication
Beyond the preview
Go deeper on 2016-004396-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004396-51.